Skip to main content

Analysts Offer Insights on Real Estate Companies: American Homes (AMH) and Healthpeak Properties (DOC)

Tipranks - Tipranks - Fri Jan 9, 8:16AM CST

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on American Homes (AMH – Research Report) and Healthpeak Properties (DOC – Research Report).

Claim 70% Off TipRanks Premium

American Homes (AMH)

In a report released today, Jeffrey Spector from Bank of America Securities maintained a Buy rating on American Homes, with a price target of $41.00. The company’s shares closed last Wednesday at $31.01.

According to TipRanks.com, Spector is a 3-star analyst with an average return of 4.1% and a 54.9% success rate. Spector covers the NA sector, focusing on stocks such as American Healthcare REIT, Inc., National Health Investors, and Rexford Industrial Realty. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for American Homes with a $36.36 average price target.

See Insiders’ Hot Stocks on TipRanks >>

Healthpeak Properties (DOC)

In a report released today, Nicholas Yulico from Scotiabank maintained a Hold rating on Healthpeak Properties, with a price target of $19.00. The company’s shares closed last Wednesday at $16.94.

According to TipRanks.com, Yulico is a 3-star analyst with an average return of 1.5% and a 45.2% success rate. Yulico covers the NA sector, focusing on stocks such as SmartStop Self Storage REIT, Inc., American Healthcare REIT, Inc., and Essential Properties Realty. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Healthpeak Properties with a $19.45 average price target, representing a 16.6% upside. In a report issued on January 5, Cantor Fitzgerald also maintained a Hold rating on the stock with a $17.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).